EU Regulatory Policy Lead
Gilead
Nasir performs Regulatory Research, Policy & Intelligence at Gilead Sciences Europe, representing the company on several trade associations. Prior roles working as a regulatory analyst at Bloomberg and as a Quality Reviewer at the MHRA, the latter where he represented the Agency on several EU working groups. Nasir trained as a scientist where he oversaw formulation development work at a drug-device firm and earlier lectured & researched at University College London on the pharmacy degree programs. He is a board-registered pharmacist and completed his PhD and postdoc work at UCL and St Jude Children’s Research Hospital in oral peptide drug delivery and cancer gene therapy, respectively.
Disclosure information not submitted.
Regulatory Intelligence and Policy Strategy; Dynamic Regulatory Assessment as a Case Study
Wednesday, May 8, 2024
15:40 – 16:40 CEST